Published in J Virol on January 01, 1999
Functional differences between human and bovine immunodeficiency virus Tat transcription factors. J Virol (2000) 1.07
Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol (2002) 1.04
Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J Virol (2000) 1.03
Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J Virol (2002) 1.00
Expanding possibilities for intervention against small ruminant lentiviruses through genetic marker-assisted selective breeding. Viruses (2013) 0.88
Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses. J Virol (2001) 0.86
The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PLoS One (2011) 0.82
Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol (1993) 17.53
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell (1989) 6.28
Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science (1989) 5.67
Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A (1985) 4.66
Conservation and prediction of solvent accessibility in protein families. Proteins (1994) 4.29
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature (1991) 3.98
Common themes in assembly and function of eukaryotic transcription complexes. Annu Rev Biochem (1995) 3.60
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol (1986) 3.45
Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell (1990) 3.27
The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev (1991) 3.24
The basics of basal transcription by RNA polymerase II. Cell (1994) 3.20
Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell (1991) 3.09
HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science (1993) 3.05
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. Proc Natl Acad Sci U S A (1991) 2.95
Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature (1994) 2.87
DNA bending by Fos and Jun: the flexible hinge model. Science (1991) 2.53
Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis. Rev Infect Dis (1985) 2.51
Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature (1990) 2.47
Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature (1994) 2.42
Infectious leukoencephalomyelitis of young goats. J Infect Dis (1974) 2.23
The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J Virol (1992) 2.19
Visna of sheep; a slow, demyelinating infection. Br J Exp Pathol (1958) 2.18
Selective DNA bending by a variety of bZIP proteins. Mol Cell Biol (1993) 2.12
Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc Natl Acad Sci U S A (1990) 1.79
Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis (1977) 1.78
Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A (1989) 1.73
Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. EMBO J (1993) 1.73
The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci U S A (1995) 1.71
Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc Natl Acad Sci U S A (1994) 1.57
Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a. Mol Cell Biol (1993) 1.53
Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats. Am J Pathol (1990) 1.42
Visna-maedi in sheep. Prog Med Virol (1974) 1.40
Fos and Jun do not bend the AP-1 recognition site. Proc Natl Acad Sci U S A (1996) 1.35
DNA-binding domains of Fos and Jun do not induce DNA curvature: an investigation with solution and gel methods. Proc Natl Acad Sci U S A (1998) 1.12
Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol Cell Biol (1989) 1.10
Chimeric proteins composed of Jun and CREB define domains required for interaction with the human T-cell leukemia virus type 1 Tax protein. J Virol (1995) 1.06
The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J Virol (1989) 1.04
Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect. Virology (1992) 0.92
The leucine zipper may induce electrophoretic mobility anomalies without DNA bending. Proc Natl Acad Sci U S A (1996) 0.91
Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains. J Virol (1994) 0.89
Involvement of FOS and JUN in the activation of visna virus gene expression in macrophages through an AP-1 site in the viral LTR. Virology (1992) 0.89
Lentivirus-induced interferon inhibits maturation and proliferation of monocytes and restricts the replication of caprine arthritis-encephalitis virus. J Virol (1989) 0.87
Lentivirus infection of macrophages. Immunol Ser (1994) 0.84
The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat. J Virol (1996) 0.80
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A (1985) 4.66
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science (1985) 4.31
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol (1986) 3.45
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology (1990) 2.33
Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol (1992) 2.30
CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A (1997) 2.23
Biology and pathogenesis of lentiviruses. J Gen Virol (1989) 2.09
High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol (1999) 2.08
LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology (2000) 2.07
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology (1993) 1.89
Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol (1997) 1.86
Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol (1997) 1.84
Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80
Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses. Proc Natl Acad Sci U S A (1986) 1.80
A DNase for apurinic/apyrimidinic sites associated with exonuclease III of Hemophilus influenzae. J Biol Chem (1978) 1.75
cis- and trans-acting transcriptional regulation of visna virus. Science (1985) 1.74
Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A (1989) 1.73
Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis (2001) 1.70
Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. Demonstration of a drug-induced deoxyribonucleic acid-enzyme complex. J Biol Chem (1975) 1.65
Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol (1997) 1.63
The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol (1987) 1.63
A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases. Science (1990) 1.63
A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60
Prep1/Pbx2 complexes regulate CCL2 expression through the -2578 guanine polymorphism. Genes Immun (2008) 1.55
Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55
Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.53
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology (2001) 1.52
Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47
Restricted replication of lentiviruses. Visna viruses induce a unique interferon during interaction between lymphocytes and infected macrophages. J Exp Med (1985) 1.46
Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeat. J Virol (1986) 1.43
Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol (1995) 1.39
Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon. J Exp Med (1985) 1.39
Genomic organization of the structural proteins of borna disease virus revealed by a cDNA clone encoding the 38-kDa protein. Virology (1993) 1.37
Slow virus-macrophage interactions. Characterization of a transformed cell line of sheep alveolar macrophages that express a marker for susceptibility to ovine-caprine lentivirus infections. Lab Invest (1984) 1.37
Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology (1996) 1.35
CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry (1999) 1.34
Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J Virol (1994) 1.33
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
The synthesis and structure of visna virus DNA. Virology (1979) 1.30
Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol (2004) 1.29
Visna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus. J Virol (1987) 1.24
Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses. J Virol (1986) 1.22
Analysis of Borna disease virus-specific RNAs in infected cells and tissues. J Gen Virol (1991) 1.19
Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin Infect Dis (1992) 1.19
Molecular cloning of unintegrated visna viral DNA and characterization of frequent deletions in the 3' terminus. Gene (1983) 1.18
Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis. Virology (1999) 1.17
Biochemical characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.15
Genomic changes associated with antigenic variation of visna virus. II. Common nucleotide sequence changes detected in variants from independent isolations. J Mol Biol (1982) 1.13
Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science (1992) 1.12
Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol Cell Biol (1989) 1.10
Antigenic variation of molecularly cloned SIVmac239 during persistent infection in a rhesus macaque. Virology (1993) 1.10
Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med (1996) 1.09
The nucleolus is the site of Borna disease virus RNA transcription and replication. J Virol (1998) 1.04
The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J Virol (1989) 1.04
SIV infection of macaques--modeling the progression to AIDS dementia. J Neurovirol (1998) 1.03
Lentiviruses of animals are biological models of the human immunodeficiency viruses. Microb Pathog (1988) 1.01
Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol (2001) 1.01
Pathogenesis of acute infection in rhesus macaques with a lymphocyte-tropic strain of simian immunodeficiency virus. J Infect Dis (1992) 1.00
A physical map of the linear unintegrated DNA of Visna virus. Virology (1981) 0.98
Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol (1997) 0.96
Analysis of virus-specific RNA species and proteins in Freon-113 preparations of the Borna disease virus. Med Microbiol Immunol (1993) 0.96
Pathogenesis of SIV pneumonia: selective replication of viral genotypes in the lung. Virology (2001) 0.96
Borna disease virus: nature of the etiologic agent and significance of infection in man. Arch Virol Suppl (1993) 0.95
Detection of IL-1 alpha and IL-1 beta in the supernatants of paraformaldehyde-treated human monocytes. Evidence against a membrane form of IL-1. J Immunol (1990) 0.95
Genotypic analysis of infant macaques infected transplacentally and orally. J Med Primatol (1996) 0.94
The CAEV tat gene trans-activates the viral LTR and is necessary for efficient viral replication. Virology (1993) 0.92
A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway. Virology (2005) 0.92
Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect. Virology (1992) 0.92
Rhesus monkey macrophages infected with simian immunodeficiency virus cause rapid lysis of CD4-bearing lymphocytes. J Gen Virol (1991) 0.92
Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication. J Virol (1988) 0.91
Pathogenesis of visna/maedi and caprine arthritis-encephalitis: new leads on the mechanism of restricted virus replication and persistent inflammation. Vet Immunol Immunopathol (1987) 0.91
A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys. J Med Primatol (1997) 0.91
Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains. J Virol (1994) 0.89
Identification of cell membrane proteins that bind visna virus. J Virol (1991) 0.89
Identification of the caprine arthritis encephalitis virus Rev protein and its cis-acting Rev-responsive element. Virology (1994) 0.89
Involvement of FOS and JUN in the activation of visna virus gene expression in macrophages through an AP-1 site in the viral LTR. Virology (1992) 0.89
Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines. J Virol (1991) 0.88
Hypothesis on the molecular basis of nononcogenic retroviral diseases. Rev Infect Dis (1985) 0.88
Topographical rearrangements of visna virus envelope glycoprotein during antigenic drift. J Virol (1987) 0.87
Neurovirulent simian immunodeficiency virus incorporates a Nef-associated kinase activity into virions. AIDS Res Hum Retroviruses (1998) 0.87
Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab. Am J Transplant (2007) 0.86
CD4-independent, CCR5-dependent simian immunodeficiency virus infection and chemotaxis of human cells. J Virol (2000) 0.86
Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nat Med (1998) 0.85
The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes. Virology (1993) 0.84
Induction of protection against Borna disease by inoculation with high-dose-attenuated Borna disease virus. Virology (1995) 0.84
Genetic and other influences on red-cell flavin enzymes, pyridoxine phosphate oxidase and glutathione reductase in families with beta-thalassaemia. Eur J Haematol (1989) 0.83
Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism. J Virol (2001) 0.83
Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein. Virology (1996) 0.83
Glutathione reductase activity and pyridoxine (pyridoxamine) phosphate oxidase activity in the red cell. Biochim Biophys Acta (1980) 0.82
Characterization of a membrane-associated protein implicated in visna virus binding and infection. Virology (2000) 0.82